臨床薬理学講座 | ||||||||
Department of Clinical Pharmacology and Therapeutics | ||||||||
整理番号 | 論文の種類 | 著者名 | タイトル | 雑誌名 書名 外 |
巻(号) | ページ | 年号 | Correns-ponding
Author |
1557001 | 原著 | Shrestha R, Hui SP, Imai H, Hashimoto S, Uemura N, Takeda S, Fuda H, Suzuki A, Yamaguchi S, Hirano KI, Chiba H. | Plasma capric acid concentrations in healthy subjects determined by high-performance liquid chromatography. | Ann Clin Biochem. | 52(5), | 588-596, | 2015 | |
1557002 | 原著 | Yamashita S, Kataoka M, Suzaki Y, Imai H, Morimoto T, Ohashi K, Inano A, Togashi K, Mutaguchi K, Sugiyama Y. | An Assessment of the Oral Bioavailability of Three Ca-Channel Blockers Using a Cassette-Microdose Study: A New Strategy for Streamlining Oral Drug Development. | J Pharm Sci. | 104(9), | 3154-3161, | 2015. | Yamashita S |
1557003 | 原著 | Iwao M, Luo JN, Tsutsumi K, Hamasaki H, Imai H, Kotegawa T. | Development and validation of high performance liquid chromatographic method for determination of pilocarpine in human plasma. | Japanese Journal of Therapeutic Drug Monitoring | 32(3), | 94-100, | 2015. | Tsutsumi K |
1557004 | 総説 | 蓮沼智子 | 治験医師からみたリスクベースのモニタリング:Corrective Action and Preventive actionの観点から. | Pharm Stage | 14 | 29-33 | 2015. | |
1557005 | proceeding | Hasunuma T, Araki N, Nakamura K, Shikano K, Momosaki K, Kawai S, Endo F, Takada F. | Significance of measureing alpha-galactosidase a in fibromyalgia patients: possibility of Fabry disease in fibromyalgia patients. | Ann Rheum Dis | 74 | 1217 | 2015. |